Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery Academic Article uri icon

Overview

MeSH Major

  • Coronary Artery Bypass
  • Myocardial Ischemia
  • Myocardium
  • Stem Cells

abstract

  • The telomere-telomerase axis, population-doubling time, and insulin-like growth factor-1 receptor expression in CSCs, together with a high circulating level of insulin-like growth factor-1, represent a novel biomarker able to predict the evolution of ischemic cardiomyopathy following revascularization.

publication date

  • January 14, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3969331

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.113.006591

PubMed ID

  • 24249720

Additional Document Info

start page

  • 157

end page

  • 72

volume

  • 129

number

  • 2